Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDIA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCSER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GNS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC42EP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRASLS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGC20647 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC01207 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM65B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JAKMIP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on